Literature DB >> 28961018

Reply to Hou et al.: Can Magnetic Resonance Imaging Effectively Evaluate the Prognosis of Patients with Pulmonary Arterial Hypertension?

Andrew J Swift1, Jim M Wild1, David G Kiely1,2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 28961018      PMCID： PMC6005242          DOI： 10.1164/rccm.201709-1842LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  8 in total

1.  Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension.

Authors:  Athénaïs Boucly; Jason Weatherald; Laurent Savale; Xavier Jaïs; Vincent Cottin; Grégoire Prevot; François Picard; Pascal de Groote; Mitja Jevnikar; Emmanuel Bergot; Ari Chaouat; Céline Chabanne; Arnaud Bourdin; Florence Parent; David Montani; Gérald Simonneau; Marc Humbert; Olivier Sitbon
Journal:  Eur Respir J       Date:  2017-08-03       Impact factor: 16.671

2.  The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension.

Authors:  N Nickel; H Golpon; M Greer; L Knudsen; K Olsson; V Westerkamp; T Welte; M M Hoeper
Journal:  Eur Respir J       Date:  2011-09-01       Impact factor: 16.671

3.  Diagnosis of pulmonary hypertension from magnetic resonance imaging-based computational models and decision tree analysis.

Authors:  Angela Lungu; Andrew J Swift; David Capener; David Kiely; Rod Hose; Jim M Wild
Journal:  Pulm Circ       Date:  2016-06       Impact factor: 3.017

4.  Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy.

Authors:  Mariëlle C van de Veerdonk; Taco Kind; J Tim Marcus; Gert-Jan Mauritz; Martijn W Heymans; Harm-Jan Bogaard; Anco Boonstra; Koen M J Marques; Nico Westerhof; Anton Vonk-Noordegraaf
Journal:  J Am Coll Cardiol       Date:  2011-12-06       Impact factor: 24.094

5.  Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).

Authors:  Raymond L Benza; Dave P Miller; Mardi Gomberg-Maitland; Robert P Frantz; Aimee J Foreman; Christopher S Coffey; Adaani Frost; Robyn J Barst; David B Badesch; C Gregory Elliott; Theodore G Liou; Michael D McGoon
Journal:  Circulation       Date:  2010-06-28       Impact factor: 29.690

6.  Magnetic Resonance Imaging in the Prognostic Evaluation of Patients with Pulmonary Arterial Hypertension.

Authors:  Andrew J Swift; Dave Capener; Chris Johns; Neil Hamilton; Alex Rothman; Charlie Elliot; Robin Condliffe; Athanasios Charalampopoulos; Smitha Rajaram; Allan Lawrie; Michael J Campbell; Jim M Wild; David G Kiely
Journal:  Am J Respir Crit Care Med       Date:  2017-07-15       Impact factor: 21.405

7.  Incremental shuttle walk test distance and autonomic dysfunction predict survival in pulmonary arterial hypertension.

Authors:  Catherine G Billings; Judith A Hurdman; Robin Condliffe; Charlie A Elliot; Ian A Smith; Matthew Austin; Iain J Armstrong; Neil Hamilton; Athanasios Charalampopoulos; Ian Sabroe; Andrew J Swift; Alexander M Rothman; Jim M Wild; Allan Lawrie; Judith C Waterhouse; David G Kiely
Journal:  J Heart Lung Transplant       Date:  2017-04-24       Impact factor: 10.247

8.  Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study.

Authors:  Christopher J Rhodes; John Wharton; Pavandeep Ghataorhe; Geoffrey Watson; Barbara Girerd; Luke S Howard; J Simon R Gibbs; Robin Condliffe; Charles A Elliot; David G Kiely; Gerald Simonneau; David Montani; Olivier Sitbon; Henning Gall; Ralph T Schermuly; H Ardeschir Ghofrani; Allan Lawrie; Marc Humbert; Martin R Wilkins
Journal:  Lancet Respir Med       Date:  2017-06-15       Impact factor: 30.700
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.